Hughes E E, Gilleland L B, Gilleland H E
Department of Microbiology and Immunology, Louisiana State University Medical Center, School of Medicine, Shreveport 71130.
Infect Immun. 1992 Sep;60(9):3497-503. doi: 10.1128/iai.60.9.3497-3503.1992.
By using the published amino acid sequence for mature outer membrane protein F of Pseudomonas aeruginosa, a computer-assisted analysis was performed to identify sites with potential as surface-exposed, antigenic regions located throughout the length of the protein molecule. Synthetic peptides 13 to 15 amino acid residues in length were synthesized for 10 such regions. Mice were immunized with each of the 10 synthetic peptides conjugated to keyhole limpet hemocyanin. An enzyme-linked immunosorbent assay (ELISA) of the antisera was performed by using each of the synthetic peptides as the ELISA antigen to verify that immunoglobulin G (IgG) antibodies capable of reacting with the peptide used as immunogen were elicited by each peptide. Each of the antipeptide antisera was screened for the presence of IgG antibodies that could bind to the surface of intact cells of strains representing the seven heterologous Fisher-Devlin immunotypes of P. aeruginosa by use of an ELISA with whole cells of the various strains as the ELISA antigen. Three peptides elicited antibodies capable of reacting with whole cells of all seven immunotype strains. Peptide 10, corresponding to amino acid residues 305 to 318, elicited whole-cell-reactive antibodies at high titers. Peptide 9, corresponding to amino acid residues 261 to 274, elicited whole-cell-reactive antibodies at more intermediate titers. Peptide 7, corresponding to amino acid residues 219 to 232, elicited such antibodies only at low titers. The carboxy-terminal portion of the mature protein appears to be the immunodominant portion. In particular, peptides 10 (NATAEGRAINRRVE) and 9 (TDAYNQKLSERRAN) appear to have potential for use as immunogens in a synthetic vaccine for immunoprophylaxis against infections caused by P. aeruginosa. Antisera from mice immunized with either peptide 9 or 10 mediated opsonophagocytic uptake by human polymorphonuclear leukocytes of wild-type cells of P. aeruginosa but exhibited no opsonic activity against a protein F-deficient mutant of P. aeruginosa.
利用已发表的铜绿假单胞菌成熟外膜蛋白F的氨基酸序列,进行了计算机辅助分析,以确定整个蛋白质分子长度上可能作为表面暴露抗原区域的位点。针对10个这样的区域合成了长度为13至15个氨基酸残基的合成肽。用与钥孔血蓝蛋白偶联的10种合成肽分别免疫小鼠。通过使用每种合成肽作为酶联免疫吸附测定(ELISA)抗原,对抗血清进行ELISA,以验证每种肽都能引发能够与用作免疫原的肽发生反应的免疫球蛋白G(IgG)抗体。通过使用以各种菌株的全细胞作为ELISA抗原的ELISA,筛选每种抗肽抗血清中是否存在能够结合代表铜绿假单胞菌七种异源Fisher-Devlin免疫型菌株完整细胞表面的IgG抗体。三种肽引发了能够与所有七种免疫型菌株的全细胞发生反应的抗体。对应于氨基酸残基305至318的肽10引发了高滴度的全细胞反应性抗体。对应于氨基酸残基261至274的肽9引发了中等滴度的全细胞反应性抗体。对应于氨基酸残基219至232的肽7仅引发了低滴度的此类抗体。成熟蛋白的羧基末端部分似乎是免疫显性部分。特别是,肽10(NATAEGRAINRRVE)和肽9(TDAYNQKLSERRAN)似乎有潜力用作合成疫苗中的免疫原,用于针对铜绿假单胞菌引起的感染进行免疫预防。用肽9或10免疫的小鼠的抗血清介导了人多形核白细胞对铜绿假单胞菌野生型细胞的调理吞噬摄取,但对铜绿假单胞菌的蛋白F缺陷突变体没有调理活性。